Search - tctmd.com

Displaying 461 - 480 of 1853

Sort: Relevancy | Date

Presentation THT 2024

Multimodal Imaging Is Needed for Early Diagnosis and Monitoring of Therapy

Presenter: Sharmila Dorbala

March 05, 2024

Presentation THT 2024

How Can We Find Cardiac Amyloidosis Not Amyloid Early?

Presenter: Frederick L. Ruberg

March 05, 2024

Presentation THT 2024

Amyloidosis Is Everywhere: Is It Really a Rare Disease?

Presenter: Mazen Hanna

March 05, 2024

Presentation THT Abstracts 2024

In-Hospital Mortality Rate and Predictors of 30-Day Readmission in Patients with Heart Failure and HIV disease-A Cross Sectional Study from Nationwide Readmission Database

Presenter: Badri Aryal

March 04, 2024

Presentation THT 2024

Overlap Between Valvular Heart Diseases and HFpEF

Presenter: Yogesh Reddy

March 04, 2024

Presentation Miami Valves 2024

Mitral Valve Disease: PMV for MAC MS

Presenter: Igor F. Palacios

February 03, 2024

Presentation Miami Valves 2024

TAVR in Bicuspid Aortic Valve Disease Where Are We Now?

Presenter: Nicolas M. Van Mieghem

February 03, 2024

Presentation Miami Valves 2024

TAVR in Bicuspid Aortic Valve Disease Where Are We Now?

Presenter: Nicolas M. Van Mieghem

February 03, 2024

Presentation Miami Valves 2024

Structural Heart Disease and Treatment

Presenter: Vivian Avila

February 03, 2024

Presentation Miami Valves 2024

Full Court Press: Is it Really Necessary in Valve Disease?

Presenter: Elliott Elias

February 01, 2024

Presentation Miami Valves 2024

Catheter Based Treatment of Structural Heart Disease: Year in Review

Presenter: Eduardo de Marchena

February 01, 2024

Presentation TCT 2023

Interventional Procedures in High-Risk Decompensated Valvular Heart Disease

Presenter: Thomas Waggoner

October 26, 2023

Presentation TCT 2023

Patient Reported Outcomes in TTVI: Are They Meaningful?

Presenter: David Cohen

October 26, 2023

Presentation TCT 2023

Review of the Current Clinical Evidence for Transcatheter Tricuspid Valve Therapies

Presenter: Susheel Kodali

October 26, 2023

Presentation TCT 2023

Current Guideline-Directed Medical Management: Will We Ever Have Class I Management Options?

Presenter: JoAnn Lindenfeld

October 26, 2023

Presentation TCT 2023

From diagnosis to treatment: the progression of disease and why we consistently undertreat AR

Presenter: Philippe Genereux

October 26, 2023

Presentation TCT 2023

What We Now Know About Tricuspid Regurgitation Outcomes: Differences in Natural History Based on Etiology

Presenter: Rebecca Hahn

October 26, 2023

Presentation TCT 2023

TCT 720: Patient-Reported Outcomes in Tricuspid Valve Intervention: Patient Preference Results from the TRISCEND II Trial

Presenter: Colin Barker

October 26, 2023

TCT 768: Early echocardiographic and hemodynamic changes after caval aortic valve implantation for severe tricuspid regurgitation

Presentation TCT 2023

TCT 768: Early Echocardiographic and Hemodynamic Changes After Caval Valve Implantation

Presenter: Ottavia Cozzi

October 26, 2023

Presentation TCT 2023

TCT 513: Real-world Clinical Outcomes and Health Care Utilization in Patients with Severe Tricuspid Regurgitation

Presenter: Mahesh Madhavan

October 26, 2023

Advertisement

Multimodal Imaging Is Needed for Early Diagnosis and Monitoring of Therapy

How Can We Find Cardiac Amyloidosis Not Amyloid Early?

Amyloidosis Is Everywhere: Is It Really a Rare Disease?

In-Hospital Mortality Rate and Predictors of 30-Day Readmission in Patients with Heart Failure and HIV disease-A Cross Sectional Study from Nationwide Readmission Database

Overlap Between Valvular Heart Diseases and HFpEF

Mitral Valve Disease: PMV for MAC MS

TAVR in Bicuspid Aortic Valve Disease Where Are We Now?

TAVR in Bicuspid Aortic Valve Disease Where Are We Now?

Structural Heart Disease and Treatment

Full Court Press: Is it Really Necessary in Valve Disease?

Catheter Based Treatment of Structural Heart Disease: Year in Review

Interventional Procedures in High-Risk Decompensated Valvular Heart Disease

Patient Reported Outcomes in TTVI: Are They Meaningful?

Review of the Current Clinical Evidence for Transcatheter Tricuspid Valve Therapies

Current Guideline-Directed Medical Management: Will We Ever Have Class I Management Options?

From diagnosis to treatment: the progression of disease and why we consistently undertreat AR

What We Now Know About Tricuspid Regurgitation Outcomes: Differences in Natural History Based on Etiology

TCT 720: Patient-Reported Outcomes in Tricuspid Valve Intervention: Patient Preference Results from the TRISCEND II Trial

TCT 768: Early Echocardiographic and Hemodynamic Changes After Caval Valve Implantation

TCT 513: Real-world Clinical Outcomes and Health Care Utilization in Patients with Severe Tricuspid Regurgitation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content